CN115501295A - 一种用于润肺止咳化痰消炎的药物颗粒及其制备方法 - Google Patents
一种用于润肺止咳化痰消炎的药物颗粒及其制备方法 Download PDFInfo
- Publication number
- CN115501295A CN115501295A CN202211274788.6A CN202211274788A CN115501295A CN 115501295 A CN115501295 A CN 115501295A CN 202211274788 A CN202211274788 A CN 202211274788A CN 115501295 A CN115501295 A CN 115501295A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- raw materials
- granule
- cough
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 79
- 206010011224 Cough Diseases 0.000 title claims abstract description 47
- 239000008187 granular material Substances 0.000 title claims abstract description 43
- 210000004072 lung Anatomy 0.000 title claims abstract description 33
- 206010061218 Inflammation Diseases 0.000 title claims abstract description 24
- 230000004054 inflammatory process Effects 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 230000003467 diminishing effect Effects 0.000 title claims abstract description 20
- 206010036790 Productive cough Diseases 0.000 title claims abstract description 12
- 208000024794 sputum Diseases 0.000 title claims abstract description 10
- 210000003802 sputum Anatomy 0.000 title claims abstract description 10
- 229940079593 drug Drugs 0.000 title claims description 17
- 239000002994 raw material Substances 0.000 claims abstract description 27
- 239000002245 particle Substances 0.000 claims abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 19
- 239000004863 Frankincense Substances 0.000 claims abstract description 18
- 238000001035 drying Methods 0.000 claims abstract description 18
- 206010062717 Increased upper airway secretion Diseases 0.000 claims abstract description 17
- 239000000463 material Substances 0.000 claims abstract description 17
- 208000026435 phlegm Diseases 0.000 claims abstract description 17
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 15
- 239000010231 banlangen Substances 0.000 claims abstract description 15
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 14
- 238000010438 heat treatment Methods 0.000 claims abstract description 13
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 12
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 12
- 241000935235 Fritillaria meleagris Species 0.000 claims abstract description 12
- 240000000691 Houttuynia cordata Species 0.000 claims abstract description 12
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 12
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 11
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 11
- 239000000843 powder Substances 0.000 claims abstract description 11
- 235000006679 Mentha X verticillata Nutrition 0.000 claims abstract description 10
- 235000002899 Mentha suaveolens Nutrition 0.000 claims abstract description 10
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims abstract description 10
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 10
- 235000011477 liquorice Nutrition 0.000 claims abstract description 10
- 238000002791 soaking Methods 0.000 claims abstract description 10
- 235000013719 Houttuynia cordata Nutrition 0.000 claims abstract description 8
- 238000000227 grinding Methods 0.000 claims abstract description 8
- 238000002156 mixing Methods 0.000 claims abstract description 8
- 240000002505 Pogostemon cablin Species 0.000 claims abstract description 7
- 235000011751 Pogostemon cablin Nutrition 0.000 claims abstract description 7
- 238000001914 filtration Methods 0.000 claims abstract description 7
- 239000007788 liquid Substances 0.000 claims abstract description 7
- 238000007789 sealing Methods 0.000 claims abstract description 7
- 239000007787 solid Substances 0.000 claims abstract description 7
- 230000001954 sterilising effect Effects 0.000 claims abstract description 7
- 238000005303 weighing Methods 0.000 claims abstract description 6
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract 3
- 241000334160 Isatis Species 0.000 claims description 18
- 241000628997 Flos Species 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 7
- 241000717739 Boswellia sacra Species 0.000 claims description 6
- 241001529821 Agastache Species 0.000 claims description 5
- 241000576429 Forsythia suspensa Species 0.000 claims description 4
- 235000013717 Houttuynia Nutrition 0.000 claims description 4
- 241001057584 Myrrha Species 0.000 claims description 4
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 4
- 241000758794 Asarum Species 0.000 claims description 3
- 244000290970 Tetrapanax papyrifer Species 0.000 claims description 3
- 241001530121 Trollius Species 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 30
- 231100000331 toxic Toxicity 0.000 abstract description 17
- 230000002588 toxic effect Effects 0.000 abstract description 17
- 240000007551 Boswellia serrata Species 0.000 abstract description 13
- 230000004044 response Effects 0.000 abstract description 2
- 201000010099 disease Diseases 0.000 description 21
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 21
- 230000001737 promoting effect Effects 0.000 description 13
- 210000002216 heart Anatomy 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 10
- 201000007100 Pharyngitis Diseases 0.000 description 10
- 206010007247 Carbuncle Diseases 0.000 description 9
- 210000002345 respiratory system Anatomy 0.000 description 9
- 230000008961 swelling Effects 0.000 description 8
- 241001570521 Lonicera periclymenum Species 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 6
- 206010068319 Oropharyngeal pain Diseases 0.000 description 6
- 238000005520 cutting process Methods 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 208000002399 aphthous stomatitis Diseases 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 208000023504 respiratory system disease Diseases 0.000 description 5
- 206010008479 Chest Pain Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 4
- 235000019658 bitter taste Nutrition 0.000 description 4
- 206010006451 bronchitis Diseases 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000027939 micturition Effects 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 206010006458 Bronchitis chronic Diseases 0.000 description 3
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 3
- QBDCOUHKEVYWLO-UHFFFAOYSA-N Decanoyl acetaldehyde Chemical compound CCCCCCCCCC(=O)CC=O QBDCOUHKEVYWLO-UHFFFAOYSA-N 0.000 description 3
- 201000000297 Erysipelas Diseases 0.000 description 3
- 206010025421 Macule Diseases 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 208000007451 chronic bronchitis Diseases 0.000 description 3
- 208000013116 chronic cough Diseases 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 210000003800 pharynx Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 210000000115 thoracic cavity Anatomy 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 210000003437 trachea Anatomy 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 241000219193 Brassicaceae Species 0.000 description 2
- 241000208229 Burseraceae Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 241000220485 Fabaceae Species 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 244000283207 Indigofera tinctoria Species 0.000 description 2
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 2
- 206010061245 Internal injury Diseases 0.000 description 2
- 241000334154 Isatis tinctoria Species 0.000 description 2
- 241000207923 Lamiaceae Species 0.000 description 2
- 201000008197 Laryngitis Diseases 0.000 description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- 208000005647 Mumps Diseases 0.000 description 2
- 206010061876 Obstruction Diseases 0.000 description 2
- 206010030302 Oliguria Diseases 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000000954 anitussive effect Effects 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- COHYTHOBJLSHDF-BUHFOSPRSA-N indigo dye Chemical compound N\1C2=CC=CC=C2C(=O)C/1=C1/C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-BUHFOSPRSA-N 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 201000003453 lung abscess Diseases 0.000 description 2
- 201000005202 lung cancer Diseases 0.000 description 2
- 208000020816 lung neoplasm Diseases 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 208000010805 mumps infectious disease Diseases 0.000 description 2
- 230000000242 pagocytic effect Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 235000019633 pungent taste Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 210000002254 renal artery Anatomy 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 241000207965 Acanthaceae Species 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 241000208828 Caprifoliaceae Species 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 201000006306 Cor pulmonale Diseases 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 206010052369 Encephalitis lethargica Diseases 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 241000555712 Forsythia Species 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- 241001278898 Glycyrrhiza inflata Species 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 241000100289 Lonicera confusa Species 0.000 description 1
- 241000173699 Lonicera dasystyla Species 0.000 description 1
- 241001170080 Lonicera hypoglauca Species 0.000 description 1
- 244000167230 Lonicera japonica Species 0.000 description 1
- 235000017617 Lonicera japonica Nutrition 0.000 description 1
- 240000000233 Melia azedarach Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 1
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000207834 Oleaceae Species 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241000382362 Persicaria tinctoria Species 0.000 description 1
- 208000002151 Pleural effusion Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000219050 Polygonaceae Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 208000004186 Pulmonary Heart Disease Diseases 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 241000612118 Samolus valerandi Species 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 241000758742 Saururaceae Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 241001121987 Scrophularia ningpoensis Species 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 241001312894 Trollius chinensis Species 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 201000004238 acute tympanitis Diseases 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000003434 antitussive agent Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 208000027697 autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency Diseases 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 201000009267 bronchiectasis Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 201000009243 chronic laryngitis Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 235000011869 dried fruits Nutrition 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 208000022760 infectious otitis media Diseases 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 206010025226 lymphangitis Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 201000011216 nasopharynx carcinoma Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000008423 pleurisy Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 201000004193 respiratory failure Diseases 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 201000002498 viral encephalitis Diseases 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/532—Agastache, e.g. giant hyssop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
- A61K36/855—Clerodendrum, e.g. glorybower
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Virology (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biochemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种用于润肺止咳化痰消炎的药物颗粒及其制备方法,该药物颗粒的原料包含:该药物颗粒的原料包含:生板蓝根、熟板蓝根、连翘、金银花、鱼腥草、广藿香、薄荷、甘草、浙贝、通草、大青叶、没药、乳香、金莲花、灯心草。本发明还提供了该药物颗粒的制备方法,该方法为:按比例称量各药物原料,干燥后研磨破碎成粉末,然后加水浸泡,再进行加热煎煮,并进行过滤,将所得的药液浓缩提纯,再与辅料混合均匀后进行干燥,最后将所得的固体进行超声破碎,得到药物颗粒,灭菌后密封装袋备用。本发明提供的药物颗粒,具有组方合理、用量少、效果显著、无毒副作用、迅速起效等特点,能够达到清热解毒、润肺止咳、化痰消炎等效果。
Description
技术领域
本发明涉及一种药物颗粒及其制备方法,具体地,涉及一种用于润肺止咳化痰消炎的药物颗粒及其制备方法。
背景技术
呼吸系统的疾病就是指组成呼吸系统的器官、组织所患的疾病,包括上呼吸道的疾病和下呼吸道的疾病。上呼吸道的疾病包括鼻炎、鼻窦炎、鼻咽癌、咽炎、喉炎等疾病,只要是发生在鼻、咽、喉部位的疾病都是上呼吸道的疾病。发生在下呼吸道的疾病包括了急性气管、支气管炎、肺炎、慢性支气管炎、慢性阻塞性肺疾病、支气管扩张等,发生于呼吸系统的疾病有很多。
呼吸系统疾病是一种常见病、多发病,主要病变在气管、支气管、肺部及胸腔,病变轻者多咳嗽、胸痛、呼吸受影响,重者呼吸困难、缺氧,甚至呼吸衰竭而致死。在城市的死亡率占第3位,而在农村则占首位。更应重视的是由于大气污染、吸烟、人口老龄化及其他因素,使国内外的慢性阻塞性肺病(简称慢阻肺,包括慢性支气管炎、肺气肿、肺心病)、支气管哮喘、肺癌、肺部弥散性间质纤维化,以及肺部感染等疾病的发病率、死亡率有增无减。
咳嗽是呼吸道疾病最常见的一种症状。咳嗽是人体一种保护性防御功能,通过咳嗽,可以排出呼吸道的分泌物或侵入气管内的异物。咳嗽可伴随咳痰。仅有咳嗽而无痰的称为干咳,可见于多种疾病。咳嗽的病因有很多,例如:慢性咽炎、慢性喉炎、慢性支气管炎、支气管哮喘、肺结核、肺癌、感染性咳嗽等,还有气管异物、胸膜炎、胸腔积液等疾病以及诸多物理、化学因素也能引起咳嗽。中医认为咳嗽分两大类,一个是外感咳嗽,一个是内伤咳嗽。外感咳嗽一般都有外感症状,比如流鼻涕、嗓子疼、发烧等等,内伤的一般就是由慢性病导致的咳嗽。
如果咳嗽不停,由急性转为慢性,常给患者带来很大的痛苦,如胸闷、咽痒、喘气等。对于长期的慢性咳嗽,需要正确用药,才能有效止咳。目前市面上的止咳药物,都有一定的缺陷,其中最突出的问题就是作用弱的止不住,作用强的副作用又太大。止咳的关键点,需要“有的放矢”地进行用药,而不是盲目的使用止咳药,否则会拖延病症,使疾病变得更加严重。
发明内容
本发明的目的是提供一种药物颗粒及其制备方法,能够解决现有问题,具有清热解毒、润肺止咳、化痰消炎等作用,从而有效减轻患者痛苦。
为了达到上述目的,本发明提供了一种用于润肺止咳化痰消炎的药物颗粒,其中,该药物颗粒的原料包含:生板蓝根、熟板蓝根、连翘、金银花、鱼腥草、广藿香、薄荷、甘草、浙贝、通草、大青叶、没药、乳香、金莲花、灯心草。
上述的用于润肺止咳化痰消炎的药物颗粒,其中,所述的原料按重量份数计包含:生板蓝根20~30份,熟板蓝根20~30份,连翘26~34份,金银花18~22份,鱼腥草18~22份,广藿香12~16份,薄荷28~32份,甘草45~55份,浙贝35~45份,通草16~24份,大青叶32~36份,没药28~32份,乳香28~32份,金莲花18~22份,灯心草18~22份。
上述的用于润肺止咳化痰消炎的药物颗粒,其中,所述的原料按重量计包含:生板蓝根25g,熟板蓝根25g,连翘30g,金银花20g,鱼腥草20g,广藿香15g,薄荷30g,甘草50g,浙贝40g,通草20g,大青叶35g,没药30g,乳香30g,金莲花20g,灯心草20g。
本发明还提供了上述的药物颗粒的制备方法,其中,所述的方法为:按比例称量各药物原料,干燥后研磨破碎成粉末,然后加水浸泡,再进行加热煎煮,并进行过滤,将所得的药液浓缩提纯,再与辅料混合均匀后进行干燥,最后将所得的固体进行超声破碎,得到药物颗粒,灭菌后密封装袋备用。
上述的药物颗粒的制备方法,其中,所述的研磨破碎的粒度范围为30~40目。
上述的药物颗粒的制备方法,其中,所述的加水浸泡的时间为8小时或以上。
上述的药物颗粒的制备方法,其中,所述的加热煎煮的时间为120~150min。
上述的药物颗粒的制备方法,其中,所述的药物颗粒用温开水送服,每天服用1~2次,每次一袋,每袋内的药物重量为12~15g。
本发明提供的用于润肺止咳化痰消炎的药物颗粒及其制备方法具有以下优点:
本发明的药物颗粒,通过天然原料提纯,消除有害残留,毒副作用小,同时保存了生物活性,经由口服吸收,具有清热解毒、润肺止咳、化痰消炎、抑菌止痛、温阳散寒等作用,同时具有组方合理、用量少、效果显著、无毒副作用、迅速起效等特点。对于长期的慢性咳嗽和其他呼吸系统疾病都能产生很好的效果,且不易复发,还可以有效杀灭大部分病毒、细菌,具有抗炎、抗菌、降糖、延缓衰老、防癌抗癌、增强免疫力、提高抵抗力等多种功能。
具体实施方式
以下对本发明的具体实施方式作进一步地说明。
本发明提供的用于润肺止咳化痰消炎的药物颗粒,该药物颗粒的原料包含:生板蓝根、熟板蓝根、连翘、金银花、鱼腥草、广藿香、薄荷、甘草、浙贝、通草、大青叶、没药、乳香、金莲花、灯心草。
其中,板蓝根为十字花科植物菘蓝的干燥根。原产我国,现各地均有栽培。入药部位为植物根部。炮制时除去杂质,洗净,润透,切厚片,干燥。味苦,性寒。归心、胃经。具有清热解毒,凉血,利咽的功效。主治外感发热,温病初起,咽喉肿痛,温毒发斑,痄腮,丹毒,痈肿疮毒。生板蓝根即为新鲜的板蓝根,熟板蓝根是加热熟制后的板蓝根。
连翘为木樨科连翘属植物连翘的干燥果实。性味苦,微寒;归肺、心、小肠经。具有清热解毒,消肿散结,疏散风热的功效。主治疮痈肿毒,瘰疬痰核,风热外感,温病初起,热淋涩痛。连翘有广谱抗菌作用,抗菌主要成分为连翘酚及挥发油,对金黄色葡萄球菌、痢疾杆菌有很强的抑制作用,对其他致病菌、流感病毒以及钩端螺旋体也均有一定的抑制作用;本品有抗炎、解热作用。所含齐墩果酸有强心、利尿及降血压作用;所含维生素P可降低血管通透性及脆性,防止溶血。其煎剂有镇吐和抗肝损伤作用。
金银花为忍冬科植物忍冬、红腺忍冬、山银花或毛花柱忍冬的干燥花蕾或带初开的花。性味甘,寒;归肺、心、胃经。具有清热解毒,疏散风热功效。主治痈肿疔疮,外感风热,温病初起,热毒血痢。药理作用包括抗病原微生物作用,抗毒作用,抗炎作用,促进炎性细胞吞噬功能作用,降血脂作用,使中枢神经兴奋,抗生育作用,对肉瘤S180和艾式腹水癌有明显的细胞毒作用等。
鱼腥草为三白草科蕺菜属植物蕺菜的干燥地上部分。本品含鱼腥草素、挥发油、蕺来碱、槲皮苷、氯化钾等。味辛,性微寒;归肺经。有清热解毒,消痈排脓,利尿通淋的功效。主治肺痈吐脓,肺热咳嗽,热毒疮痈,湿热淋证,湿热泻痢。本品能增强白细胞吞噬能力,提高机体免疫力并有抗炎作用。所含槲皮素及钾盐能扩张肾动脉,增加肾动脉血流量,因而有较强的利尿作用。此外,还有镇痛、止血、促进组织再生和伤口愈合以及镇咳等作用。
广藿香为唇形科植物广藿香的干燥地上部分。枝叶茂盛时采割,日晒夜闷,反复至干。味辛,性微温。归脾、胃、肺经。具有芳香化浊,和中止呕,发表解暑的功效。用于湿浊中阻,脘痞呕吐,暑湿表证,湿温初起,发热倦怠,胸闷不舒,寒湿闭暑,腹痛吐泻,鼻渊头痛。
薄荷为唇形科植物;广泛分布于全国各地,多生于山野湿地河旁,根茎横生地下,是一种有特种经济价值的芳香作物。全草或叶入药。除去老茎和杂质,略喷清水,稍润,切短段,及时低温干燥。味辛,性凉;入肺、肝经;功效为疏散风热、清利头目、利咽透疹、疏肝行气;主治外感风热、头痛、咽喉肿痛、食滞气胀、口疮、牙痛、疮疥、瘾疹、温病初起、风疹瘙痒、肝郁气滞、胸闷胁痛。
甘草为豆科植物甘草、胀果甘草或光果甘草的干燥根和根茎。春,秋二季采挖,除去须根,晒干。味甘,性平。归心、肺、脾、胃经。具有补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药之功效。常用于脾胃虚弱,倦怠乏力,心悸气短,咳嗽痰多,脘腹、四肢挛急疼痛,痈肿疮毒,缓解药物毒性、烈性。
浙贝即浙贝母,为百合科贝母属植物浙贝母的鳞茎。分布浙江、江苏、安徽、湖南等地。浙江宁波地区有大量栽培。初夏植株枯萎时采挖,洗净,擦去外皮,拌以煅过的贝壳粉,吸去浆汁,切厚片或打成碎块。含浙贝母碱,去氢浙贝母碱,浙贝宁、浙贝酮,贝母醇,浙贝宁苷等。味苦,性寒;归肺、心经。具有清热化痰,散结消痈的功效。主治风热、痰热咳嗽,瘰疬,瘿瘤,乳痈疮毒,肺痈。
通草为五加科植物通脱木的干燥茎髓。主产于广西、四川、贵州、云南。秋季割取茎,截成段,趁鲜取出髓部,理直,晒干。除去杂质,切厚片。味甘、淡,性微寒。归肺、胃经。有清热利尿,通气下乳的功效。用于湿热淋证,水肿尿少,乳汁不下。
大青叶的来源包括爵床科植物马蓝,十字花科植物菘蓝及大青,蓼科植物蓼蓝,豆科植物木蓝,以上植物的叶都做为大青叶使用。味苦,性寒。归肝,心,胃,脾经。功效为清热解毒,凉血消斑。用于热病高热烦渴;神昏;斑疹;吐血;衄血;黄疸;泻痢;丹毒;喉痹;口疮;痄腮。主治:热毒发斑、丹毒、咽喉肿痛、口舌生疮、疮痈肿毒等症。近年来此药在临床上广泛应用,除可用治上述诸症外,又可用于痰热郁肺、咯痰黄稠;尤常用于流行性乙性脑炎,既可单味应用于预防,又可配合柴胡、金银花、连翘、板蓝根、玄参、生地等,能清解气分、营分的热毒,可用治各种乙脑,而以偏热型较为合适。
没药为橄榄科植物地丁树或哈地丁树的干燥树脂。分为天然没药和胶质没药。分布于索马里、埃塞俄比亚及阿拉伯半岛南部等地。味辛、苦,性平。归心、肝、脾经。具有散瘀定痛,消肿生肌的功效。用于胸痹心痛,胃脘疼痛,痛经经闭,产后瘀阻,癥瘕腹痛,风湿痹痛,跌打损伤,痈肿疮疡等病症的治疗。
乳香为橄榄科植物乳香树及同属植物树皮渗出的树脂。分为索马里乳香和埃塞俄比亚乳香,每种乳香又弁为乳香珠和原乳香。性味辛、苦,温。归心、肝、脾经。具有活血行气止痛,消肿生肌的功效。用于胸痹心痛,胃脘疼痛,痛经经闭,产后瘀阻,症瘕腹痛,风湿痹痛,筋脉拘挛,跌打损伤,痈肿疮疡。
金莲花为毛茛科植物金莲花或亚洲金莲花的花。产自山西等地。夏季花盛开时采收,晾干。味苦,性寒,无毒。功能主治为:清热解毒。治上感,扁桃体炎,咽炎,急性中耳炎,急性鼓膜炎,急性结膜炎,急性淋巴管炎,口疮,疔疮。金莲花含生物碱、黄酮类。金莲花用酸水提取,碱化后再用氯仿转提所得的提取物,对革兰氏阳性球菌及阴性杆菌都有抑制作用,对绿脓杆菌的抗菌作用,尤为明显。
灯心草为灯心草科植物灯心草的干燥茎髓。主产于江西、江苏、福建、四川、贵州、云南。以植物的干燥茎髓,抽芯或晾干切碎入药。在夏末至秋季割取茎,晒干,取出茎髓,理直,扎成小把。味甘、淡,性微寒。归心、肺、小肠经。具有清心火,利小便的功效。用于心烦失眠,尿少涩痛,口舌生疮。
优选地,该原料按重量份数计包含:生板蓝根20~30份,熟板蓝根20~30份,连翘26~34份,金银花18~22份,鱼腥草18~22份,广藿香12~16份,薄荷28~32份,甘草45~55份,浙贝35~45份,通草16~24份,大青叶32~36份,没药28~32份,乳香28~32份,金莲花18~22份,灯心草18~22份。
更优选地,该原料按重量计包含:生板蓝根25g,熟板蓝根25g,连翘30g,金银花20g,鱼腥草20g,广藿香15g,薄荷30g,甘草50g,浙贝40g,通草20g,大青叶35g,没药30g,乳香30g,金莲花20g,灯心草20g。
各原料均采用野生中草药材,多年生的采用五年或以上的药材。取材自野生珍稀动植物的,在条件不允许的情况下可以采用取自人工养殖和种植的材料,或其他效果等同以及效果接近的替代物。
本发明还提供了该药物颗粒的制备方法,该方法为:按比例称量各药物原料,干燥后研磨破碎成粉末,然后加水浸泡,再进行加热煎煮,并进行过滤,将所得的药液浓缩提纯,再与辅料混合均匀后进行干燥,最后将所得的固体进行超声破碎,得到药物颗粒,灭菌后密封装袋备用。
优选地,研磨破碎的粒度范围为30~40目。
加水浸泡的时间为8小时或以上。所加的水和药材原料总量的质量比为(10~15):1。
加热煎煮的时间为120~150min。
所得的药物颗粒用温开水送服,每天服用1~2次,每次一袋,每袋内的药物重量为12~15g。
下面结合实施例对本发明提供的用于润肺止咳化痰消炎的药物颗粒及其制备方法做更进一步描述。
实施例1
一种用于润肺止咳化痰消炎的药物颗粒,该药物颗粒的原料按重量计包含:生板蓝根25g,熟板蓝根25g,连翘30g,金银花20g,鱼腥草20g,广藿香15g,薄荷30g,甘草50g,浙贝40g,通草20g,大青叶35g,没药30g,乳香30g,金莲花20g,灯心草20g。
本实施例还提供了该药物颗粒的制备方法,该方法为:按比例称量各药物原料,干燥后研磨破碎成粉末,研磨破碎的粒度范围为30~40目。然后加水浸泡,加水浸泡的时间为8小时或以上。再进行加热煎煮,加热煎煮的时间为120~150min。并进行过滤,将所得的药液浓缩提纯,再与辅料混合均匀后进行干燥,最后将所得的固体进行超声破碎,得到药物颗粒,灭菌后密封装袋备用。
所得的药物颗粒用温开水送服,每天服用1~2次,每次一袋,每袋内的药物重量为12~15g。
实施例2
一种用于润肺止咳化痰消炎的药物颗粒,该药物颗粒的原料按重量计包含:生板蓝根20g,熟板蓝根20g,连翘26g,金银花18g,鱼腥草18g,广藿香12g,薄荷28g,甘草45g,浙贝35g,通草16g,大青叶32g,没药28g,乳香28g,金莲花18g,灯心草18g。
本实施例还提供了该药物颗粒的制备方法,该方法为:按比例称量各药物原料,干燥后研磨破碎成粉末,研磨破碎的粒度范围为30~40目。然后加水浸泡,加水浸泡的时间为8小时或以上。再进行加热煎煮,加热煎煮的时间为120~150min。并进行过滤,将所得的药液浓缩提纯,再与辅料混合均匀后进行干燥,最后将所得的固体进行超声破碎,得到药物颗粒,灭菌后密封装袋备用。
所得的药物颗粒用温开水送服,每天服用1~2次,每次一袋,每袋内的药物重量为12~15g。
实施例3
一种用于润肺止咳化痰消炎的药物颗粒,该药物颗粒的原料按重量计包含:生板蓝根30g,熟板蓝根30g,连翘34g,金银花22g,鱼腥草22g,广藿香16g,薄荷32g,甘草55g,浙贝45g,通草24g,大青叶36g,没药32g,乳香32g,金莲花22g,灯心草22g。
本实施例还提供了该药物颗粒的制备方法,该方法为:按比例称量各药物原料,干燥后研磨破碎成粉末,研磨破碎的粒度范围为30~40目。然后加水浸泡,加水浸泡的时间为8小时或以上。再进行加热煎煮,加热煎煮的时间为120~150min。并进行过滤,将所得的药液浓缩提纯,再与辅料混合均匀后进行干燥,最后将所得的固体进行超声破碎,得到药物颗粒,灭菌后密封装袋备用。
所得的药物颗粒用温开水送服,每天服用1~2次,每次一袋,每袋内的药物重量为12~15g。
各实施例中采用的原料分别符合相应的国家标准。
采用各实施例制备的药物颗粒进行临床试用,结果证明该药物颗粒能够清热解毒、润肺止咳、化痰消炎,可以用于长期的慢性咳嗽和其他呼吸系统疾病,具有明显效果。
本发明提供的用于润肺止咳化痰消炎的药物颗粒及其制备方法,经中医辨证,针对病证的病因病机,利用药物相辅相成的配伍原理,有目的地将诸药按君、臣、佐、使的组织结构合理配伍,使方中的药物及其配伍与病证的病机丝丝入扣,使药物配伍后的综合效用与所立治法高度统一。在具体实施时遵循中医药理论,首先用中医四诊(望、闻、问、切)诊疗,结合西医化验等结果为依据,根据患者年龄、体质用药,分君、臣、佐、使,护助引经药物相配伍,合理运用升降沉浮的归经应用,内外结合,进行使用。所得的药物颗粒又名月佛颗粒。
尽管本发明的内容已经通过上述优选实施例作了详细介绍,但应当认识到上述的描述不应被认为是对本发明的限制。在本领域技术人员阅读了上述内容后,对于本发明的多种修改和替代都将是显而易见的。因此,本发明的保护范围应由所附的权利要求来限定。
Claims (8)
1.一种用于润肺止咳化痰消炎的药物颗粒,其特征在于,该药物颗粒的原料包含:生板蓝根、熟板蓝根、连翘、金银花、鱼腥草、广藿香、薄荷、甘草、浙贝、通草、大青叶、没药、乳香、金莲花、灯心草。
2.如权利要求1所述的用于润肺止咳化痰消炎的药物颗粒,其特征在于,所述的原料按重量份数计包含:生板蓝根20~30份,熟板蓝根20~30份,连翘26~34份,金银花18~22份,鱼腥草18~22份,广藿香12~16份,薄荷28~32份,甘草45~55份,浙贝35~45份,通草16~24份,大青叶32~36份,没药28~32份,乳香28~32份,金莲花18~22份,灯心草18~22份。
3.如权利要求2所述的用于润肺止咳化痰消炎的药物颗粒,其特征在于,所述的原料按重量计包含:生板蓝根25g,熟板蓝根25g,连翘30g,金银花20g,鱼腥草20g,广藿香15g,薄荷30g,甘草50g,浙贝40g,通草20g,大青叶35g,没药30g,乳香30g,金莲花20g,灯心草20g。
4.一种如权利要求1~3中任意一项所述的药物颗粒的制备方法,其特征在于,所述的方法为:按比例称量各药物原料,干燥后研磨破碎成粉末,然后加水浸泡,再进行加热煎煮,并进行过滤,将所得的药液浓缩提纯,再与辅料混合均匀后进行干燥,最后将所得的固体进行超声破碎,得到药物颗粒,灭菌后密封装袋备用。
5.如权利要求4所述的药物颗粒的制备方法,其特征在于,所述的研磨破碎的粒度范围为30~40目。
6.如权利要求4所述的药物颗粒的制备方法,其特征在于,所述的加水浸泡的时间为8小时或以上。
7.如权利要求4所述的药物颗粒的制备方法,其特征在于,所述的加热煎煮的时间为120~150min。
8.如权利要求4所述的药物颗粒的制备方法,其特征在于,所述的药物颗粒用温开水送服,每天服用1~2次,每次一袋,每袋内的药物重量为12~15g。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211274788.6A CN115501295A (zh) | 2022-10-18 | 2022-10-18 | 一种用于润肺止咳化痰消炎的药物颗粒及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211274788.6A CN115501295A (zh) | 2022-10-18 | 2022-10-18 | 一种用于润肺止咳化痰消炎的药物颗粒及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115501295A true CN115501295A (zh) | 2022-12-23 |
Family
ID=84510962
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211274788.6A Pending CN115501295A (zh) | 2022-10-18 | 2022-10-18 | 一种用于润肺止咳化痰消炎的药物颗粒及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115501295A (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104800660A (zh) * | 2015-05-19 | 2015-07-29 | 王丽 | 一种治疗肺炎支原体肺炎的中药制剂及其制备方法 |
CN105079225A (zh) * | 2014-05-22 | 2015-11-25 | 北京以岭药业有限公司 | 一种中药组合物在制备治疗支气管扩张药物中的应用 |
CN105617095A (zh) * | 2016-01-27 | 2016-06-01 | 朱德密 | 一种用于小儿急性上呼吸道感染的口服液及制备方法 |
CN107007687A (zh) * | 2017-04-24 | 2017-08-04 | 沈蓉蓉 | 一种金银花感冒颗粒 |
CN109550017A (zh) * | 2018-12-26 | 2019-04-02 | 叶柳兴 | 清肺热消炎化痰止咳中药配方 |
-
2022
- 2022-10-18 CN CN202211274788.6A patent/CN115501295A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105079225A (zh) * | 2014-05-22 | 2015-11-25 | 北京以岭药业有限公司 | 一种中药组合物在制备治疗支气管扩张药物中的应用 |
CN104800660A (zh) * | 2015-05-19 | 2015-07-29 | 王丽 | 一种治疗肺炎支原体肺炎的中药制剂及其制备方法 |
CN105617095A (zh) * | 2016-01-27 | 2016-06-01 | 朱德密 | 一种用于小儿急性上呼吸道感染的口服液及制备方法 |
CN107007687A (zh) * | 2017-04-24 | 2017-08-04 | 沈蓉蓉 | 一种金银花感冒颗粒 |
CN109550017A (zh) * | 2018-12-26 | 2019-04-02 | 叶柳兴 | 清肺热消炎化痰止咳中药配方 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104208393B (zh) | 一种用于防治鸡传染性支气管炎的中药组合物及其制备方法 | |
CN103800650B (zh) | 一种治疗清肺化痰的中药 | |
CN113730479A (zh) | 一种具有保健功能的组合物及其制备方法与用途 | |
CN103860835A (zh) | 一种纯中药制剂的多用途兽药 | |
CN104706830B (zh) | 一种预防家禽病毒中药散剂 | |
CN104225026B (zh) | 用于治疗急慢性咽喉炎、上呼吸道感染、病毒性感染药物 | |
CN108478500B (zh) | 一种用于口腔的组合物及其应用 | |
CN105943963A (zh) | 一种治疗猪肺炎的药物 | |
CN115501295A (zh) | 一种用于润肺止咳化痰消炎的药物颗粒及其制备方法 | |
CN103599328B (zh) | 一种治疗肺泡蛋白沉着症的中药 | |
CN104306753B (zh) | 一种蜜蜂诱蜂液及其制作方法 | |
CN111700948A (zh) | 一种预防和治疗新冠肺炎的外用中药及其制备方法 | |
CN103536788B (zh) | 一种治疗毛发红糠疹的中药 | |
CN102935170B (zh) | 一种治疗化脓性门静脉炎的中药 | |
CN105941953A (zh) | 一种用于豚鼠饲养的饲料添加剂 | |
CN104922648A (zh) | 一种治疗鸡腹泻的中药组合物及其制备方法 | |
CN105663649A (zh) | 一种治疗咽炎的中药组合物及其制备方法 | |
CN105055657A (zh) | 一种改善智齿带来的疼痛的喷剂及其制备方法 | |
CN110772598A (zh) | 一种治疗口疮的组合物、其应用及服用方法 | |
CN103623232A (zh) | 一种治疗支气管炎的中药 | |
CN104161963A (zh) | 治疗羊肺炎的内服中药散 | |
CN103316252A (zh) | 一种治疗肝纤维化的中药 | |
CN103585470B (zh) | 一种治疗肺炎球菌肺炎的中药 | |
CN103610928B (zh) | 一种治疗过敏性紫癜性肾炎的中药 | |
CN114344434B (zh) | 一种治疗肺结节的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |